AP Pharma makes new appointment
This article was originally published in Scrip
Executive Summary
The US speciality pharmaceutical company AP Pharma has named John Whelan vice-president of finance and chief financial officer. He succeeds Gregory Turnbull, who was serving as interim chief financial officer and will remain a company director and a member of the board's executive committee. Mr Whelan was previously chief operating officer and chief financial officer at Raven biotechnologies.